Mirjana V. Magic-Brankovic

Belgrade, SE, Serbia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Mutational profile of hereditary breast and ovarian cancer - Establishing genetic testing guidelines in a developing country.

Mutational profile of hereditary breast and ovarian cancer - Establishing genetic testing guidelines in a developing country.

Journal: Current problems in cancer

Published: August 27, 2020

Expression of SIRT1, SIRT3 and SIRT6 Genes for Predicting Survival in Triple-Negative and Hormone Receptor-Positive Subtypes of Breast Cancer.

Expression of SIRT1, SIRT3 and SIRT6 Genes for Predicting Survival in Triple-Negative and Hormone Receptor-Positive Subtypes of Breast Cancer.

Journal: Pathology oncology research : POR

Published: June 17, 2019

Confirmation of damaging effect of MSH2 c.2634+1G>C mutation on splicing, its classification and implications for counseling.

Confirmation of damaging effect of MSH2 c.2634+1G>C mutation on splicing, its classification and implications for counseling.

Journal: Cancer genetics

Published: April 12, 2019

Germline mutations in cancer susceptibility genes in high grade serous ovarian cancer in Serbia.

Germline mutations in cancer susceptibility genes in high grade serous ovarian cancer in Serbia.

Journal: Journal of human genetics

Published: September 07, 2018

Promoter hypermethylation of p16, BRCA1 and RASSF1A genes in triple-negative breast cancer patients from Serbia.

Promoter hypermethylation of p16, BRCA1 and RASSF1A genes in triple-negative breast cancer patients from Serbia.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: July 14, 2018

Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy.

Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy.

Journal: BMC cancer

Published: November 01, 2017

Polymorphisms in cancer susceptibility genes XRCC1, RAD51 and TP53 and the risk of breast cancer in Serbian women.

Polymorphisms in cancer susceptibility genes XRCC1, RAD51 and TP53 and the risk of breast cancer in Serbian women.

Journal: The International journal of biological markers

Published: February 24, 2016

RAD51C mutation screening in high-risk patients from Serbian hereditary breast/ovarian cancer families.

RAD51C mutation screening in high-risk patients from Serbian hereditary breast/ovarian cancer families.

Journal: Cancer biomarkers : section A of Disease markers

Published: September 26, 2015

RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women.

RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women.

Journal: Familial cancer

Published: October 12, 2013

CHEK2 1100delC and Del5395bp mutations in BRCA-negative individuals from Serbian hereditary breast and ovarian cancer families.

CHEK2 1100delC and Del5395bp mutations in BRCA-negative individuals from Serbian hereditary breast and ovarian cancer families.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: September 26, 2013

Association of TLR2, TLR3, TLR4 and CD14 genes polymorphisms with oral cancer risk and survival.

Association of TLR2, TLR3, TLR4 and CD14 genes polymorphisms with oral cancer risk and survival.

Journal: Oral diseases

Published: February 22, 2013

Serbian high-risk families: extensive results on BRCA mutation spectra and frequency.

Serbian high-risk families: extensive results on BRCA mutation spectra and frequency.

Journal: Journal of human genetics

Published: December 21, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026